Immaturity, perinatal inflammation, and retinopathy of prematurity: a multi-hit hypothesis

Olaf Dammann1, Maria-Jantje Brinkhaus, Dorothee B Bartels

  • 1Division of Newborn Medicine, Floating Hospital for Children at Tufts Medical Center, Boston, MA 02111, USA. odammann@tuftsmedicalcenter.org

Early Human Development
|February 17, 2009
PubMed

Insights

Inflammation markers, both before and after birth, increase the risk of retinopathy of prematurity (ROP) in premature infants. This includes clinical signs of infection and inflammatory conditions like chorioamnionitis.

Area of Science:

  • Neonatalogy
  • Ophthalmology
  • Genetics

Background:

  • Retinopathy of prematurity (ROP) is a significant cause of visual impairment in preterm infants.
  • Infection and inflammation are suspected contributors to ROP development and progression.

Purpose of the Study:

  • To investigate the association between infection/inflammation markers and the risk of developing ROP.
  • To determine if these markers influence the progression to severe stages of ROP.

Main Methods:

  • A cohort of 73 preterm infants (gestational age <32 weeks) was studied.
  • Clinical data and genetic polymorphisms in infection/inflammation-associated genes were analyzed.
  • Statistical methods included descriptive and analytic approaches.

Main Results:

  • Clinical markers of infection/inflammation were linked to a higher risk of ROP and progression to ROP grade 3.
  • Genetic markers did not correlate with ROP occurrence but were associated with progression to high-grade disease.
  • Low gestational age (<29 weeks) was the primary risk factor, with clinical chorioamnionitis and neonatal systemic inflammatory response syndrome further increasing ROP progression risk.

Conclusions:

  • Both prenatal and postnatal exposure to inflammation contribute to ROP risk in preterm infants.
  • Clinical signs of inflammation are key indicators for ROP risk and progression.
Abstract